Today's Headlines

Today's Headlines - 09 December 2023

India-Korea Electronic Origin Data Exchange System (EODES)

GS Paper II

News Excerpt:

Recently, India and South Korea have launched the India-Korea Electronic Origin Data Exchange System (EODES).


Space ‘Hamburger’ through James Web Space Telescope

GS Paper III

News Excerpt: 

Astronomers have used the James Webb Space Telescope (JWST) to paint a picture of burger-shaped, planet-forming material around a young star.


Boost to UPI Limits for Health & Edu and Regulatory Framework for Digital Lending

GS Paper III

News Excerpt:

RBI enhances UPI payment limits and proposes rules for web-aggregation of loans and the creation of  a Fintech Repository.


Special Economic Zones (Fifth Amendment) Rules, 2023

GS Paper III

News Excerpt:
The Government has amended the Special Economic Zones (SEZ) Rules to permit the demarcation of a portion of the built-up area in an IT/ITES (Information Technology/Information Technology Enabled Services) SEZ as a non-processing area.


Also in News


MSF (Marginal Standing Facility) and SDF (Standing Deposit Facility)

News Excerpt:

The Reserve Bank of India has adjusted its liquidity management tools SDF and MSF as part of monetary policy review.


China starts up the world's first fourth-generation nuclear reactor

News Excerpt:

China has started commercial operations at a new-generation nuclear reactor that is the first of its kind in the world.


Indian Star Tortoise

News Excerpt:

The Border Security Force (BSF) has thwarted a cross-border wildlife smuggling attempt and rescued 296 Indian star tortoises which were being smuggled to Bangladesh.


Interest Equalisation Scheme

News Excerpt: 

The Union Cabinet has approved an additional allocation of Rs 2500 Cr for continuation of the Interest Equalization Scheme till 30th June 2024.


DRESS Syndrome

News Excerpt: 

The Indian Pharmacopoeia Commission (IPC) issued an advisory about the side effects of Meftal, a commonly consumed painkiller - as it could be a reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.


Gene therapies for Sickle Cell Disease

News Excerpt:
The U.S. The Food and Drug Administration (FDA) approves two gene therapies for sickle cell, bringing hope to thousands with the disease.

Book A Free Counseling Session

What's Today

Reviews